Post, Anke <br/><br/>
A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies.  [electronic resource] 

 -  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology  06 2016 
 - 1803-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1740-634X 
<br/><br/><label>Standard No.: </label>10.1038/npp.2015.348  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Anti-Anxiety Agents--pharmacology<br/>Chlordiazepoxide--pharmacology<br/>Depression--drug therapy<br/>Disease Models, Animal<br/>Double-Blind Method<br/>Eye Movements--drug effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Mice<br/>Middle Aged<br/>Narcotic Antagonists--therapeutic use<br/>Prefrontal Cortex--drug effects<br/>Pregnancy<br/>Pyrans--therapeutic use<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Opioid--metabolism<br/>Spiro Compounds--therapeutic use<br/>Young Adult<br/>Nociceptin Receptor